This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Nature Reviews | |
|---|---|
| Title | Nature Reviews |
| Discipline | Scientific publishing |
| Abbreviation | Nat. Rev. |
| Publisher | Springer Nature |
| Country | United Kingdom |
| History | 2000s–present |
| Frequency | Monthly |
| ISSN | 1471-0072 |
Nature Reviews
Nature Reviews is an umbrella title for a suite of high-profile review journals published by Springer Nature known for synthesizing advances across life sciences, physical sciences, and clinical research. The family gathers authoritative overviews, commentaries, and perspectives from prominent authors affiliated with institutions such as Harvard University, Max Planck Society, University of Oxford, Stanford University, and Johns Hopkins University. Its articles are often cited in policy discussions at bodies like World Health Organization and European Commission, and are referenced in award citations for prizes including the Nobel Prize and the Lasker Award.
Nature Reviews comprises multiple subject-specific titles that provide commissioned, peer-reviewed review articles, structured to serve researchers at research-intensive institutions including Massachusetts Institute of Technology, Imperial College London, University of Cambridge, and California Institute of Technology. Editors recruit authors from research centers such as the National Institutes of Health and the CNRS to produce narratives that connect breakthroughs reported in journals like Nature, Science, Cell, The Lancet, and PNAS. Readership spans faculty, postdoctoral researchers, clinicians at hospitals like Mayo Clinic, and policy analysts at organizations such as Bill & Melinda Gates Foundation.
The inception of the Nature Reviews series built on the editorial model of legacy titles including Nature Biotechnology and Nature Medicine, with early strategic development influenced by leadership from publishing figures tied to Macmillan Publishers and Springer-Verlag. Launch phases involved collaboration with scientific advisory boards drawn from universities such as University of California, Berkeley and research institutes like Salk Institute. Over time, the brand expanded through editorial appointments of figures affiliated with University College London and research partnerships with consortia including Wellcome Trust. The series adapted to shifting digital distribution paradigms pioneered by platforms like PubMed Central and commercial aggregators such as Web of Science and Scopus.
The portfolio includes titles focused on discrete domains: for life sciences, editors oversee titles addressing topics covered at conferences such as the Cold Spring Harbor Laboratory meetings; for clinical practice, specialists connected to Royal College of Physicians or American College of Cardiology contribute commissions; for physical sciences, contributors often hail from institutes like CERN or Lawrence Berkeley National Laboratory. Sub-journals in the family cover areas analogous to the scopes of established journals such as Nature Genetics, Nature Neuroscience, Nature Materials, Nature Chemistry, and Nature Physics, while engaging communities represented by societies like the American Society for Microbiology and the Biophysical Society.
Editorial policy emphasizes commissioned reviews, author expertise validated by affiliations with institutions such as Princeton University and ETH Zurich, and a structured peer-review process involving external reviewers drawn from laboratories at Scripps Research and clinical centers like Cleveland Clinic. Conflict-of-interest management references standards exemplified by institutions like COPE and procedures akin to editorial policies used by The New England Journal of Medicine and BMJ Group. Decisions on content balance and topicality are informed by citation metrics from indexing services including Google Scholar and Clarivate Analytics as well as by committees modelled on advisory boards at Royal Society.
Articles from the series frequently appear in citation analyses alongside papers from Nature Communications and Science Advances. The titles are influential in shaping review literature used in major reports from bodies like Intergovernmental Panel on Climate Change and United Nations Environment Programme. Reception in academic communities often references endorsement by research groups at Cold Spring Harbor Laboratory and by consortia such as the Human Genome Project participants. Critiques of the family have paralleled debates around commercial publishing raised by advocates at Public Library of Science and campaigns like Plan S.
Notable commissioned pieces have synthesized landmark findings from projects such as the Human Microbiome Project and the Human Cell Atlas, and have offered perspectives intersecting disciplines represented by conferences like Society for Neuroscience and American Chemical Society meetings. Series addressing emergent topics—examples include immunotherapy insights linked to American Association for Cancer Research findings and structural biology reviews tied to advances at Protein Data Bank—have been widely cited in both academic literature and clinical guideline discussions from bodies such as National Institute for Health and Care Excellence.
Content distribution leverages platforms and discovery services including Nature.com hosting, indexing by MEDLINE and Embase, and institutional subscriptions managed through library consortia such as JISC and CARL. Access models engage subscription-based institutional licensing used by universities like Yale University and hybrid open-access options paralleling policies at Elsevier. Archiving partnerships and preservation practices reference initiatives such as CLOCKSS and Portico to ensure long-term availability for readers at museums, universities, and research institutes worldwide.
Category:Academic journals